Question:

Is Q5102 still the code to assign for an injection of the biosimilar infliximab?

Answer:

Code Q5102, which describes both currently available versions of infliximab biosimilars, is the correct code to assign but only until March 31, 2018. It will be discontinued effective for claims with dates of service on or after April 1, 2018 and will be replaced with the two codes below.

Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.